Literature DB >> 11164402

Complications of fracture of the neck of the femur in children. A long-term follow-up study.

H A Morsy 1.   

Abstract

This is a long-term study of 53 children with fracture of the proximal femur. The age of these children at the time of injury ranged from 3 to 16 years (average, 10.2 years). The follow-up period averaged 9.4 years (range, 5-20 years). There was a single transepiphyseal fracture, 28 transcervical fractures, 21 basicervical fractures and three intertrochanteric fractures. The overall results were good in 49, fair in 25 and poor in 26% of patients. Better results were obtained in undisplaced fractures and in those displaced fractures where anatomical reduction was achieved and maintained throughout fracture healing. The rate of early and delayed complications was 60%, with some patients having more than one complication. Avascular necrosis occurred in 40%. It was found to be related to initial fracture displacement and was associated was an inferior outcome. Other complications included coxa vara in 36, non-union in 36, premature physeal closure in 38, shortening in 55, arthritic changes in 34, coxa valga in 9, coxa magna in 2, and post-operative infection in 23% of patients. The quality of reduction appeared to influence the occurrence of some complications such as avascular necrosis and non-union.

Entities:  

Mesh:

Year:  2001        PMID: 11164402     DOI: 10.1016/s0020-1383(00)00109-1

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  24 in total

1.  [Open pertrochanteric fracture of the femur and post-traumatic osteitis in a child : Interposition of a pedicled vascularized fibula to preserve the femoral head].

Authors:  B Hussmann; G Taeger; R Hierner; D Nast-Kolb; S Lendemans
Journal:  Unfallchirurg       Date:  2011-11       Impact factor: 1.000

2.  Pediatric Hip Fractures in California: Results from a Community-Based Hip Fracture Registry.

Authors:  Heather A Prentice; Elizabeth W Paxton; Jessica J Hunt; Christopher D Grimsrud; Jennifer M Weiss
Journal:  Perm J       Date:  2017

3.  Operative treatment of avascular necrosis of the femoral head after proximal femur fractures in adolescents.

Authors:  Jan Bartoníček; Jaroslav Vávra; Radek Bartoška; Petr Havránek
Journal:  Int Orthop       Date:  2011-07-28       Impact factor: 3.075

4.  Delayed Slipped Capital Femoral Epiphysis After Treatment of Femoral Neck Fracture in Children.

Authors:  Hai Li; Li Zhao; Luyu Huang; Ken N Kuo
Journal:  Clin Orthop Relat Res       Date:  2014-11-27       Impact factor: 4.176

5.  Management pitfalls of fractured neck of femur in osteogenesis imperfecta.

Authors:  Wang Chow; Rajiv Negandhi; Evelyn Kuong; Michael To
Journal:  J Child Orthop       Date:  2013-03-29       Impact factor: 1.548

6.  Post-traumatic coxa vara in children following screw fixation of the femoral neck.

Authors:  Robert Eberl; Georg Singer; Peter Ferlic; Annelie M Weinberg; Michael E Hoellwarth
Journal:  Acta Orthop       Date:  2010-08       Impact factor: 3.717

7.  Femoral Neck Fractures in Children: A Follow-Up Study of 19 Cases.

Authors:  Masoud Norouzi; Mohamad N Naderi
Journal:  Eur J Trauma Emerg Surg       Date:  2008-10-09       Impact factor: 3.693

8.  Neglected femoral neck fracture in patient with seizure: a case of a delayed fixation of type 1A fracture in 11-month-old infant.

Authors:  Halil Atmaca; Kaya Memişoğlu; Tuncay Baran
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-05-15

9.  Pediatric femur neck fractures: a retrospective analysis of 39 hips.

Authors:  Ulukan Inan; Nusret Köse; Hakan Omeroğlu
Journal:  J Child Orthop       Date:  2009-05-26       Impact factor: 1.548

10.  Initial displacement as a risk factor for avascular necrosis of the femoral head in pediatric femoral neck fractures: a review of one hundred eight cases.

Authors:  Wentao Wang; Yiqiang Li; Yueming Guo; Ming Li; Haibo Mei; Jingfan Shao; Zhu Xiong; Jin Li; Federico Canavese; Shunyou Chen
Journal:  Int Orthop       Date:  2019-10-26       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.